Integrated Master in Pharmaceutical Sciences

Pharmacotherapy I

ECTS

5

Learning outcomes

Students have to learn each teaching disease learning the most recent therapeutic strategies recommended by national and international guidelines. Students have to learn to analyze the outcomes of therapeutic interventions and the adjustment needs in what concerns of drug selection or drug combinations in view to get the best clinical outcomes and drug safety. Students have also to learn the main recommendations that are adjuvant of pharmacotherapy to have better clinical outcomes. Students have to be able to differentiate several kinds of clinical guidelines and to solve clinical cases.

Syllabus

Diseases from cardiovascular system, endocrine/metabolic and digestive tract are characterized teaching the most update recommended therapeutic strategies. These strategies are recommended at clinical practice at national and European levels. Cardiovascular diseases: hypertension, isquemic coronary disease, heart failure, arterial fibrillation, thromboembolic diseases, dyslipidemia. Gastrointestinal diseases: hepatic diseases, peptic ulcer, gastroesofagic reflux, intestinal inflammatory diseases, diarrhea, constipation, nausea, vomiting, digestive problems. Endocrine/metabolic diseases: diabetes mellitus 1 and 2, thyroid affections, adrenal affections, menopause, andropause, osteoporosis. Corticotherapy. Discussions about the different guidelines published by scientific societies at national and international levels, how to characterize them and evaluate.

Share